The store will not work correctly when cookies are disabled.
3-ethoxycarbonyl-4-(2-methoxyphenyl)-4H-pyridine-1-carboxylic acid phenyl ester
ID: ALA229468
PubChem CID: 44424118
Max Phase: Preclinical
Molecular Formula: C22H21NO5
Molecular Weight: 379.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)C1=CN(C(=O)Oc2ccccc2)C=CC1c1ccccc1OC
Standard InChI: InChI=1S/C22H21NO5/c1-3-27-21(24)19-15-23(22(25)28-16-9-5-4-6-10-16)14-13-17(19)18-11-7-8-12-20(18)26-2/h4-15,17H,3H2,1-2H3
Standard InChI Key: ARVLBNCGYZTGLR-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
5.2444 -5.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2432 -6.4607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9581 -6.8735 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6745 -6.4602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6716 -5.6297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9563 -5.2205 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9579 -7.6985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2403 -8.1109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2382 -8.9323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9507 -9.3488 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6671 -8.9377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6709 -8.1101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9474 -10.1738 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2312 -10.5834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.6602 -10.5892 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5184 -10.1680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5263 -9.3434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8144 -8.9281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0972 -9.3378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0966 -10.1670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8091 -10.5786 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3863 -7.6992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0999 -8.1133 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3882 -6.8742 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5284 -6.8726 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8143 -6.4595 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8153 -7.7024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5288 -8.1165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
13 14 1 0
7 3 1 0
13 15 2 0
7 8 1 0
14 16 1 0
3 4 2 0
16 17 2 0
17 18 1 0
4 5 1 0
18 19 2 0
2 3 1 0
19 20 1 0
5 6 2 0
20 21 2 0
21 16 1 0
7 12 1 0
12 22 1 0
8 9 2 0
22 23 1 0
9 10 1 0
22 24 2 0
10 11 1 0
2 25 1 0
11 12 2 0
25 26 1 0
6 1 1 0
23 27 1 0
10 13 1 0
27 28 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 379.41 | Molecular Weight (Monoisotopic): 379.1420 | AlogP: 4.25 | #Rotatable Bonds: 5 |
Polar Surface Area: 65.07 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 4.00 | CX LogD: 4.00 |
Aromatic Rings: 2 | Heavy Atoms: 28 | QED Weighted: 0.73 | Np Likeness Score: -0.13 |
References
1. Voigt B, Coburger C, Monár J, Hilgeroth A.. (2007) Structure-activity relationships of novel N-acyloxy-1,4-dihydropyridines as P-glycoprotein inhibitors., 15 (15): [PMID:17533131] [10.1016/j.bmc.2007.05.036] |